Form 4 for BDSX BIODESIX INC
Accepted 2022-11-21 00:00:00 ET · period of report 2022-11-21 · accession 0001140361-22-042595 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-21 | 2022-11-21 | BDSX | Georgantas Robert William III | CSO | A - Grant | $1.15 | +12.0K | 38.1K | +46% | +$13.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | A | A | 12,000 | $1.15 | 38,114 | D | — | — |